Chuanhui Cao
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
Papers in
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 2
- Co-authors
- Dehua Wu (17 shared papers)Li Liu (11 shared papers)Dongyan Zhang (6 shared papers)Jingyuan Sun (12 shared papers)Zhenru Zhu (9 shared papers)Xuejun Guo (2 shared papers)Xin Li (1 shared paper)Liwei Xie (1 shared paper)
- Journals
- Ecotoxicology and Environmental Safety (4 papers)Gastroenterology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Genomics & Proteomics (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Chuanhui Cao
22 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 62
- Cancer Research 520
- Molecular Biology 652
- Oncology 184
- Immunology 102
- Hepatology 28
Countries citing papers authored by Chuanhui Cao
This map shows the geographic impact of Chuanhui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanhui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanhui Cao more than expected).
Fields of papers citing papers by Chuanhui Cao
This network shows the impact of papers produced by Chuanhui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanhui Cao. The network helps show where Chuanhui Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Chuanhui Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 215 | |
| 2 | 2020 | 175 | |
| 3 | 2018 | 99 | |
| 4 | 2015 | 81 | |
| 5 | 2016 | 77 | |
| 6 | 2018 | 74 | |
| 7 | 2020 | 74 | |
| 8 | 2016 | 58 | |
| 9 | 2020 | 46 | |
| 10 | 2022 | 41 | |
| 11 | 2021 | 34 | |
| 12 | 2012 | 22 | |
| 13 | 2024 | 14 | |
| 14 | 2024 | 7 | |
| 15 | 2024 | 7 | |
| 16 | 2023 | 6 | |
| 17 | [miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3]. | 2014 | 4 |
| 18 | Knockdown of UACA inhibitsproliferation and invasion and promotes senescence of hepatocellular carcinoma cells. | 2018 | 4 |
| 19 | 2024 | 4 | |
| 20 | [Effect of casein kinase 2β in esophageal carcinoma and its clinical significance]. | 2012 | 2 |
About Chuanhui Cao
Chuanhui Cao is a scholar working on Molecular Biology, Cancer Research, Health, Toxicology and Mutagenesis, Oncology and Immunology, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (2 papers), interferon and immune responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Anesthesia and Neurotoxicity Research (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (520 citations), Molecular Biology (652 citations), Oncology (184 citations), Immunology (102 citations) and Hepatology (28 citations). Chuanhui Cao has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Dehua Wu, Li Liu, Dongyan Zhang, Jingyuan Sun, Zhenru Zhu, Xuejun Guo, Xin Li, Liwei Xie, Ze-Qin Guo and Shengni Hua. Their work appears in journals such as Ecotoxicology and Environmental Safety, Gastroenterology, Journal for ImmunoTherapy of Cancer, Cancer Genomics & Proteomics and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.